CIBC World Market
PDLI

CIBC World Market’s PDL BioPharma, Inc. PDLI Stock Holding History

CIBC World Market’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-52,170
Closed -$174K – 1008
2016
Q1 		$174K Buy
52,170
+16,175
+45% +$50.4K ﹤0.01% 808
2015
Q4 		$127K Sell
35,995
-210,333
-85% -$880K ﹤0.01% 830
2015
Q3 		$1.24M Sell
246,328
-47,716
-16% -$273K 0.01% 411
2015
Q2 		$1.89M Buy
294,044
+63,916
+28% +$428K 0.01% 345
2015
Q1 		$1.62M Sell
230,128
-112,136
-33% -$812K 0.01% 344
2014
Q4 		$2.64M Buy
342,264
+17,653
+5% +$140K 0.01% 279
2014
Q3 		$2.42M Buy
324,611
+29,884
+10% +$277K 0.01% 258
2014
Q2 		$2.85M Buy
294,727
+17,459
+6% +$156K 0.01% 236
2014
Q1 		$2.3M Buy
277,268
+64,930
+31% +$557K 0.01% 258
2013
Q4 		$1.79M Buy
212,338
+45,349
+27% +$382K 0.01% 276
2013
Q3 		$1.33M Buy
166,989
+30,740
+23% +$247K 0.01% 282
2013
Q2 		$1.05M Buy
+136,249
New +$1.06M ﹤0.01% 297

Other funds holding PDLI

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
EA
Emerald Acquisition Seattle, Washington $51.8B AUM

CIBC World Market's PDLI Position: Q2 2016 in Review

CIBC World Market sold out of PDL BioPharma, Inc. (PDLI) in Q2 2016, closing a stake of 52,170 shares — an estimated $174K sold.

CIBC World Market first reported a position in PDLI in Q2 2013 and held it in 12 quarters. The position peaked at $2.85M in Q2 2014. 201 funds tracked by Wall St. Rank hold PDLI as of Q2 2016.

  • CIBC World Market reported no remaining PDL BioPharma, Inc. position as of Q2 2016 after selling out during the quarter.
  • CIBC World Market sold 52,170 PDL BioPharma, Inc. shares in Q2 2016, an estimated $174K.
  • CIBC World Market first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 12 quarters.
  • CIBC World Market's PDL BioPharma, Inc. position peaked at $2.85M in Q2 2014.
  • 201 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q2 2016.

Based on CIBC World Market's 13F filing for Q2 2016, filed 21 Jul 2016.